Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Living in the golden age of psoriasis and atopic dermatitis therapies Next Article
Letter from The Editor »
« Living in the golden age of psoriasis and atopic dermatitis therapies Next Article
Letter from The Editor »
Table of Contents: AAD 2018
Featured articles
Letter from The Editor
Living in the golden age of psoriasis and atopic dermatitis therapies
Late-breakers
IL-17C inhibition in AD and new oral treatments
Dual JAK/SYK inhibitor and anti-IL-33 blockade
Psoriasis: Selective IL-23 blocker, analysis of VOYAGE-2, dual IL-17 inhibitor and ustekinumab
Hyperhidrosis: Soft molecule and anticholinergic towelettes
Behcet’s syndrome and hidradenitis suppurativa
Psoriasis: an update
Oral therapeutics, supersaturation and excimer laser
Psoriasis management online?
What's hot in atopic dermatitis
AD sleep disturbance, antihistamines and osteoporosis
New topical and systematic treatments
Acne management
Winter effect and preventing scarring
Restrictive antibiotic use and novel tetracycline
Alopecia Areata
Melanoma
Melanoma incidence continues to rise in Europe
Lesions in paediatric patients and possible correlation with coffee drinking
CNNs and targeted combination therapy
Pearls of the posters
Improvement in impact of genital psoriasis on sexual activity with use of ixekizumab
Intralesional cryosurgery and itching in psoriasis
Related Articles
December 20, 2018
A glimpse into the future
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy